Medscape To Develop FDA Biosimilars Educational Program

Courses Will Be Created To Enhance HCPs’ Understanding Of Biosimilars

21 Feb 2022

Medscape Education has been awarded an FDA contract to develop an educational program about biosimilars for US healthcare professionals, which is set to launch in spring this year.

Doctors having lecture and taking notes in meeting room — Pharmacists' understanding of biosimilars is becoming increasingly crucial as more interchangeable products reach the US market • Source: Alamy

Medscape Education, a continuous professional development firm for healthcare professionals that is part of the WebMD network, has been awarded a contract from the US Food and Drug Administration to develop an educational curriculum and outreach programs on the use of biosimilars in medical practice.

The program of accredited continuing education courses for physicians, pharmacists and nurses will cover a broad range of topics on...